首页> 外文期刊>American journal of otolaryngology >Complete response to weekly carboplatin-docetaxel chemotherapy in a 91-year-old woman with anaplastic thyroid cancer
【24h】

Complete response to weekly carboplatin-docetaxel chemotherapy in a 91-year-old woman with anaplastic thyroid cancer

机译:一名91岁变性甲状腺癌妇女对每周卡铂-多西他赛化疗的完全反应

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Anaplastic thyroid cancer (ATC) is an unusual tumor with the worst prognosis among thyroid malignancies. Treatment of the patients diagnosed with ATC is not standardized and the feasible options include surgery, radiotherapy and chemotherapy. ATC cannot be regarded as a very chemo-sensitive tumor. Herein, we reported a case of a 91-year-old woman with complete response after induction chemotherapy (weekly carboplatin and docetaxel) that underwent subsequent radiotherapy. (C) 2015 Elsevier Inc. All rights reserved.
机译:间变性甲状腺癌(ATC)是甲状腺恶性肿瘤中预后最差的罕见肿瘤。诊断为ATC的患者的治疗方法尚未标准化,可行的选择包括手术,放疗和化疗。 ATC不能被视为对化学非常敏感的肿瘤。在本文中,我们报道了一例91岁的女性,在接受诱导化疗(每周卡铂和多西他赛)后完全缓解,并接受了后续放疗。 (C)2015 Elsevier Inc.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号